Topics › Drug Policy › Psychedelics
Commentary by Gregory Ferenstein and Leonard Gilroy
Commentary by Gregory Ferenstein
Testimony by Geoffrey Lawrence
Commentary by Madison Carlino
Policy Brief by Madison Carlino
Commentary by Gregory Ferenstein and Madison Carlino